JNH — Jack Nathan Medical Share Price
Last trade - 00:00- CA$2.61m
- CA$16.11m
- CA$19.14m
- 11
- 68
- 12
- 20
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | n/a | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.12 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | n/a | ||
| Return on Equity | n/a | ||
| Operating Margin | -27.62% | ||
Financial Summary
| Year End 31st Jan | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CA$m | 3.62 | 3.85 | 9.64 | 15.49 | 19.14 | n/a | n/a | 45.61% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Jack Nathan Medical Corp., operating as Jack Nathan Health, is a Canada-based healthcare company that is improving access for millions of patients by co-locating physicians and ancillary medical services conveniently inside Walmart stores. Jack Nathan Health provides patient care, made possible through patient-centric physicians, a variety of medical services, technology, and programs, designed to put patients first. It has turn-key medical centers in approximately 168 corporately owned and operated locations globally. In Mexico, the Company has approximately 161 corporate owned clinics, including 155 retail clinics in Walmart locations, five clinics inside Walmart Distribution Centers servicing Walmart Associates, and one large format multidisciplinary clinic in Mexico City. In Canada, there are four Rehab clinics and three MedSpa clinics, all of which are corporate owned and operated.
Directors
- Neil Labatte NEC (60)
- Michael Marchelletta PRE
- David Berman CFO (59)
- Michael Cesare COO
- Anthony DeCristofaro IND
- Blake Lyon IND (52)
- Last Annual
- January 31st, 2024
- Last Interim
- October 31st, 2024
- Incorporated
- May 31st, 2017
- Public Since
- May 23rd, 2019
- No. of Employees
- 24
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- TSX Venture Exchange
- Shares in Issue
- 87,099,159
- Address
- 6-6150 Highway 6,, Suite 491, WOODBRIDGE, L4H 0R6
- Web
- https://www.jacknathanhealth.com/
- Phone
- +1 4166372240
- Auditors
- MNP LLP
Upcoming Events for JNH
Similar to JNH
AJA Health And Wellness
TSX Venture Exchange
ARCpoint
TSX Venture Exchange
Cannara Biotech
TSX Venture Exchange
Element Lifestyle Retirement
TSX Venture Exchange
Leveljump Healthcare
TSX Venture Exchange
FAQ
As of Today at 20:24 UTC, shares in Jack Nathan Medical are trading at CA$0.03. This share price information is delayed by 15 minutes.
Shares in Jack Nathan Medical last closed at CA$0.03 and the price had moved by -40% over the past 365 days. In terms of relative price strength the Jack Nathan Medical share price has underperformed the Toronto Stock Exchange 300 Composite Index by -49.96% over the past year.
There is no consensus recommendation for this security.
Find out moreJack Nathan Medical does not currently pay a dividend.
Jack Nathan Medical does not currently pay a dividend.
Jack Nathan Medical does not currently pay a dividend.
To buy shares in Jack Nathan Medical you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of CA$0.03, shares in Jack Nathan Medical had a market capitalisation of CA$2.61m.
Here are the trading details for Jack Nathan Medical:
- Country of listing: Canada
- Exchange: CVE
- Ticker Symbol: JNH
Based on an overall assessment of its quality, value and momentum Jack Nathan Medical is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Jack Nathan Medical. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -21.79%.
As of the last closing price of CA$0.03, shares in Jack Nathan Medical were trading -28.83% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Jack Nathan Medical PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at CA$0.03.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Jack Nathan Medical's management team is headed by:
- Neil Labatte - NEC
- Michael Marchelletta - PRE
- David Berman - CFO
- Michael Cesare - COO
- Anthony DeCristofaro - IND
- Blake Lyon - IND